Dr. Peter J. Snyder, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
3400 Civic Center Blvd, West Pavilion, 4th Floor
Philadelphia, PA 19104
- Medicare participating
At a glance
- Medical school
- Harvard Medical School (1965)
- Years since graduation
- 61
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 129
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1965Medical school: Harvard Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
PA license MD012727E
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hospital of Univ of Pennsylvania Philadelphia, PA
- Penn Presbyterian Medical Center Philadelphia, PA
- Chester County Hospital West Chester, PA
- Pennsylvania Hospital Philadelphia, PA
Medical groups
- University of Penn - Medical Group (3,505 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 129
- Services billed
- 263
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 93 | 75 |
| Established patient office or other outpatient visit, 40-54 minutes | 84 | 57 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydrocortisone Other prescribers in Philadelphia, PA | 282 |
| Levothyroxine Sodium Other prescribers in Philadelphia, PA | 226 |
| Testosterone Other prescribers in Philadelphia, PA | 176 |
| Synthroid (levothyroxine sodium) Other prescribers in Philadelphia, PA | 90 |
| Cabergoline | 68 |
| Somavert (pegvisomant) | 63 |
| Somatuline Depot (lanreotide acetate) | 48 |
| Desmopressin Acetate Other prescribers in Philadelphia, PA | 40 |
| Fludrocortisone Acetate Other prescribers in Philadelphia, PA | 34 |
| Sandostatin Lar Depot (octreotide acetate,mi-spheres) | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $950 in research payments for these studies, mostly to the institutions running them.
- LCI699-RECAG-PASS-0572
Recordati_rare_diseases_inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.